2021 annual financial data
SAB Biotherapeutics, Inc. - Warrant 2021 Operating margin
SAB Biotherapeutics, Inc. - Warrant 2021 operating margin with verified reporte…
Direct answer
Operating margin was -22%.
Operating income was -13,393,000 USD and net income was -17,145,000 USD.
Operating cash flow was 1,986,873 USD.
Get free SAB Biotherapeutics, Inc. - Warrant email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 60,876,000 USD
- Operating income
- -13,393,000 USD
- Net income
- -17,145,000 USD
- Operating cash flow
- 1,986,873 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all SAB Biotherapeutics, Inc. - Warrant financial years